EB
Emily Bodnar HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
97
Avg Return
Past Year
Past Year
18%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
94.7%
Neutral
5.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Medical Devices
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $39 |
186%
upside
| 2 | +0.69% |
0
%
| 13 Jan ‘26 7 days ago |
|
|
|
Neutral
Downgraded
| $14 |
1%
upside
| 2 | +70% |
0
%
| 8 Jan ‘26 12 days ago |
|
|
|
Buy
Maintained
| $62 |
128%
upside
| 2 | -2.3% |
0
%
| 24 Dec ‘25 27 days ago |
|
|
|
Buy
Maintained
| $47 |
32%
upside
| 1 | +45% |
0
%
| 19 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $32 |
47%
upside
| 2 | +36% |
0
%
| 12 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $45 |
66%
upside
| 3 | +50% |
0
%
| 11 Dec ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $19 |
860%
upside
| 1 | -25% |
0
%
| 25 Nov ‘25 1 month ago |
|
|
|
Buy
Maintained
| $51 |
12%
upside
| 2 | +19% |
0
%
| 24 Nov ‘25 1 month ago |
|
|
|
Buy
Maintained
| $15 |
239%
upside
| 1 | +48% |
0
%
| 12 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $9 |
97%
upside
| 1 | +37% |
0
%
| 7 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $5 |
247%
upside
| 1 | +27% |
0
%
| 6 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $72 |
105%
upside
| 1 | +96% |
0
%
| 27 Oct ‘25 2 months ago |
|